glp 1 optic nerve GLP-1 Users May Face Damage Risk in First Year Study Disputes Link Between GLP-1

As per the findings of a recent study, glucagon-like peptide-1 receptor agonists (GLP-1 RAs) may substantially lower the risk of atrial fibrillation (AF) in people with heart failure with preserved ejection fraction (HFpEF) and heart failure with mildly reduced ejection fraction (HfmrEF)

It is much more palatable and easier to take

Deussing JM, Chen A

We discuss experimental data to consider potential mechanisms by which metabolic abnormalities could generate attacks

The promising preclinical results have now paved the way for evaluating the use of GLP-1R agonists in clinical studies with neurodegenerative diseases such as Alzheimers disease , Parkinsons disease , stroke , and diabetic neuropathy